THE FOUNDATION FOR AIDS RESEARCH: Form 990, tax year 2013

View the entire original 990 at ProPublica ↗

Organization
THE FOUNDATION FOR AIDS RESEARCH (EIN 13-3163817)
Tax period
2013-10-01 to 2014-09-30
Filed
2015-06-25
IRS object ID
201541769349300449
Schema version
2013v4.0
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2015-06-25T15:00:54-05:00ReturnTs
Tax Period End2014-09-30TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1GRANT THORNTON LLPBusinessNameLine1

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line1757 THIRD AVE 2ND FLOORAddressLine1
CityNEW YORKCity
StateNYState
ZIP Code100172013ZIPCode
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2013-10-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN133163817EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1THE FOUNDATION FOR AIDS RESEARCHBusinessNameLine1
FieldValueIRS element (for citing)
In Care Of% BRADLEY JENSENInCareOfNm
Business Name ControlFOUNBusinessNameControlTxt
Phone2128061600PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1120 wall street 13TH FLOORAddressLine1
Address Line2SuiteAddressLine2
CityNEW YORKCity
StateNYState
ZIP Code100053908ZIPCode

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonBradley JensenPersonNm
Person TitleCFOPersonTitleTxt
Phone2128061703PhoneNum
Signature2015-06-23SignatureDt
Discuss With Paid PreparerYes (true)DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonScott ThompsettPreparerPersonNm
PTINP00741490PTIN
Phone2128061703PhoneNum
FieldValueIRS element (for citing)
Tax2013TaxYr
Build TS2016-04-25 22:37:26ZBuildTS

Form 990 IRS990

Doing Business As Name DoingBusinessAsName

FieldValueIRS element (for citing)
Business Name Line1Aids Research Foundation or AMFARBusinessNameLine1
FieldValueIRS element (for citing)
Principal OfficerKEVIN FROSTPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line1120 WALL STREET 13TH FLOORAddressLine1
Citynew yorkCity
StateNYState
ZIP Code10005ZIPCode
FieldValueIRS element (for citing)
Gross Receipts$77,370,757GrossReceiptsAmt
Group Return For AffiliatesfalseGroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressWWW.AMFAR.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1983FormationYr
Legal Domicile StateNYLegalDomicileStateCd
Activity Or Missionamfar is dedicated to ending the global AIDS EPIDEMIC THROUGH INNOVATIVE RESEARCH.ActivityOrMissionDesc
Voting Members Governing Body20VotingMembersGoverningBodyCnt
Voting Members Independent20VotingMembersIndependentCnt
Total Employee92TotalEmployeeCnt
Total Volunteers160TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
PY Contributions Grants$38,582,579PYContributionsGrantsAmt
CY Contributions Grants$57,556,516CYContributionsGrantsAmt
PY Program Service Revenue$0PYProgramServiceRevenueAmt
CY Program Service Revenue$0CYProgramServiceRevenueAmt
PY Investment Income$980,398PYInvestmentIncomeAmt
CY Investment Income$1,225,465CYInvestmentIncomeAmt
PY Other Revenue-$9,648,345PYOtherRevenueAmt
CY Other Revenue-$10,881,866CYOtherRevenueAmt
PY Total Revenue$29,914,632PYTotalRevenueAmt
CY Total Revenue$47,900,115CYTotalRevenueAmt
PY Grants And Similar Paid$7,997,283PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$9,928,384CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$9,333,804PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$9,582,859CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$470,337PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$569,004CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$5,153,653CYTotalFundraisingExpenseAmt
PY Other Expenses$11,457,241PYOtherExpensesAmt
CY Other Expenses$14,312,877CYOtherExpensesAmt
PY Total Expenses$29,258,665PYTotalExpensesAmt
CY Total Expenses$34,393,124CYTotalExpensesAmt
PY Revenues Less Expenses$655,967PYRevenuesLessExpensesAmt
CY Revenues Less Expenses$13,506,991CYRevenuesLessExpensesAmt
Total Assets BOY$50,024,337TotalAssetsBOYAmt
Total Assets EOY$57,895,971TotalAssetsEOYAmt
Total Liabilities BOY$18,892,314TotalLiabilitiesBOYAmt
Total Liabilities EOY$13,585,624TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$31,132,023NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$44,310,347NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionTHE FOUNDATION FOR AIDS RESEARCH IS AN INTERNATIONAL NOT-FOR-PROFIT ORGANIZATION INCORPORATED IN NEW YORK IN 1989. AMFAR WAS FORMED THROUGH THE UNIFICATION IN 1985 OF TWO NOT-FOR-PROFIT ORGANIZATIONS, THE AIDS MEDICAL FOUNDATION ("AMF"), INCORPORATED IN NEW YORK IN APRIL 1983, AND THE NATIONAL AIDS RESEARCH FOUNDATION, INCORPORATED IN CALIFORNIA IN AUGUST 1985. FIRST BASED IN CALIFORNIA, AMFAR TRANSFERRED ITS LEGAL DOMICILE TO NEW YORK IN 1989, USING THE INITIAL INCORPORATION DOCUMENTS OF AMF, MAKING IT AMF'S LEGAL SUCCESSOR. AMFAR HAS OFFICES IN NEW YORK, NY, WASHINGTON, D.C., AND BANGKOK, THAILAND. ON MARCH 7, 2005, THE BOARD OF TRUSTEES OF THE AMERICAN FOUNDATION FOR AIDS RESEARCH APPROVED A CHANGE IN LEGAL NAME TO "THE FOUNDATION FOR AIDS RESEARCH." ON OCTOBER 18, 2005, THE NEW YORK STATE DEPARTMENT OF STATE APPROVED THIS CHANGE. IN ADDITION, THE FOUNDATION HAS SECURED APPROVAL FOR DOING BUSINESS AS (DBA) THE FOLLOWING: - AMERICAN FOUNDATION FOR AIDS RESEARCH - AMFAR - AIDS RESEARCMissionDesc
Significant New Program SrvcfalseSignificantNewProgramSrvcInd
Significant ChangefalseSignificantChangeInd
Expense$11,765,284ExpenseAmt
Grant$5,482,076GrantAmt
Revenue$0RevenueAmt
DescRESEARCH: amfAR supports research projects that explore novel approaches to scientifically sound but untested hypotheses in all areas of research on HIV/AIDS, funding goal-oriented studies that often lack the preliminary data required for support from traditional grant-makers. The Foundation plays a vital role in HIV/AIDS research, identifying critical gaps in knowledge and providing essential seed money that enables grantees and fellows to test the merits of new concepts or technologies that subsequently can be validated through large-scale studies, such as those funded by the National Institutes of Health. FOR FURTHER DETAILS, SEE SCHEDULE O.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$6,754,069ExpenseAmt
Grant$3,275,924GrantAmt
Revenue$0RevenueAmt
DescTREAT ASIA: amfAR's TREAT Asia program (Therapeutics Research, Education, and AIDS Training in Asia) involves a network of hospitals, clinics, and research institutions working with civil society to ensure the safe and effective delivery of HIV/AIDS treatments across Asia and the Pacific. The TREAT Asia Network encompasses 21 adult and 18 pediatric sites throughout the region, which collaborate on a variety of projects. FOR FURTHER DETAILS, SEE SCHEDULE O.Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$3,625,752ExpenseAmt
Grant$0GrantAmt
Revenue$0RevenueAmt
DescEDUCATION AND INFORMATION: amfAR seeks to translate and disseminate information on important AIDS-related research, treatment, prevention, and policy issues for diverse audiences and to increase broad awareness and knowledge of the pandemic. amfAR also publishes a wide range of educational materials, maintains an informative website, and engages respected public figures, HIV/AIDS scientists, and policymakers in communicating the need for continued research on HIV/AIDS. FOR FURTHER DETAILS, SEE SCHEDULE O.Desc

Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp (2 entries)

ExpenseExpenseAmtGrantGrantAmtRevenueRevenueAmtDescDesc
$2,388,396$875,445$0GMT Initiative
$2,233,490$294,939$0public policy
FieldValueIRS element (for citing)
Total Other Prog Srvc Expense$4,621,886TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Grant$1,170,384TotalOtherProgSrvcGrantAmt
Total Other Prog Srvc Revenue$0TotalOtherProgSrvcRevenueAmt
Total Program Service Expenses$26,766,991TotalProgramServiceExpensesAmt
Described In Section501c3Yes (true)DescribedInSection501c3Ind
Schedule B RequiredYes (true)ScheduleBRequiredInd
Political Campaign ActyfalsePoliticalCampaignActyInd
Lobbying ActivitiesYes (true)LobbyingActivitiesInd
Subject To Proxy TaxfalseSubjectToProxyTaxInd
Donor Advised FundfalseDonorAdvisedFundInd
Conservation EasementsfalseConservationEasementsInd
Collections Of ArtYes (true)CollectionsOfArtInd
Credit CounselingfalseCreditCounselingInd
Temp Or Permanent EndowmentsYes (true)TempOrPermanentEndowmentsInd
Report Land Building EquipmentYes (true)ReportLandBuildingEquipmentInd
Report Investments Other SecfalseReportInvestmentsOtherSecInd
Report Program Related InvstfalseReportProgramRelatedInvstInd
Report Other AssetsfalseReportOtherAssetsInd
Report Other LiabilitiesYes (true)ReportOtherLiabilitiesInd
Include FIN48 FootnoteYes (true)IncludeFIN48FootnoteInd
Independent Audit Fincl StmtYes (true)IndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtfalseConsolidatedAuditFinclStmtInd
School OperatingfalseSchoolOperatingInd
Foreign OfficeYes (true)ForeignOfficeInd
Foreign ActivitiesYes (true)ForeignActivitiesInd
More Than5000 K To OrgYes (true)MoreThan5000KToOrgInd
More Than5000 K To IndividualsfalseMoreThan5000KToIndividualsInd
Professional FundraisingYes (true)ProfessionalFundraisingInd
Fundraising ActivitiesYes (true)FundraisingActivitiesInd
Gaming ActivitiesfalseGamingActivitiesInd
Operate HospitalfalseOperateHospitalInd
Grants To OrganizationsYes (true)GrantsToOrganizationsInd
Grants To IndividualsfalseGrantsToIndividualsInd
Schedule J RequiredYes (true)ScheduleJRequiredInd
Tax Exempt BondsfalseTaxExemptBondsInd
Engaged In Excess Benefit TransfalseEngagedInExcessBenefitTransInd
PY Excess Benefit TransfalsePYExcessBenefitTransInd
Loan OutstandingfalseLoanOutstandingInd
Grant To Related PersonfalseGrantToRelatedPersonInd
Business Rln With Org MemfalseBusinessRlnWithOrgMemInd
Business Rln With Fam MemfalseBusinessRlnWithFamMemInd
Business Rln With Officer EntfalseBusinessRlnWithOfficerEntInd
Deductible Non Cash ContriYes (true)DeductibleNonCashContriInd
Deductible Art ContributionfalseDeductibleArtContributionInd
Terminate OperationsfalseTerminateOperationsInd
Partial LiquidationfalsePartialLiquidationInd
Disregarded EntityfalseDisregardedEntityInd
Related EntityfalseRelatedEntityInd
Related Organization Ctrl EntfalseRelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd OrgfalseTrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted PrtshpfalseActivitiesConductedPrtshpInd
Schedule O RequiredYes (true)ScheduleORequiredInd
IRP Document112IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (true)BackupWthldComplianceInd
Employee92EmployeeCnt
Employment Tax Returns FiledYes (true)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over LimitfalseUnrelatedBusIncmOverLimitInd
Foreign Financial AccountYes (true)ForeignFinancialAccountInd
Foreign CountryTHForeignCountryCd
Prohibited Tax Shelter TransfalseProhibitedTaxShelterTransInd
Taxable Party NotificationfalseTaxablePartyNotificationInd
Nondeductible ContributionsfalseNondeductibleContributionsInd
Quid Pro Quo ContributionsYes (true)QuidProQuoContributionsInd
Quid Pro Quo Contri DisclYes (true)QuidProQuoContriDisclInd
Form8282 Property Disposed OffalseForm8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft CntrctfalseRcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft CntrctfalsePayPremiumsPrsnlBnftCntrctInd
Indoor Tanning ServicesfalseIndoorTanningServicesInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members20GoverningBodyVotingMembersCnt
Independent Voting Member20IndependentVotingMemberCnt
Family Or Business RlnfalseFamilyOrBusinessRlnInd
Delegation Of Mgmt DutiesfalseDelegationOfMgmtDutiesInd
Change To Org DocumentsfalseChangeToOrgDocumentsInd
Material Diversion Or MisusefalseMaterialDiversionOrMisuseInd
Members Or StockholdersfalseMembersOrStockholdersInd
Election Of Board MembersfalseElectionOfBoardMembersInd
Decisions Subject To ApprovafalseDecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (true)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (true)MinutesOfCommitteesInd
Officer Mailing AddressfalseOfficerMailingAddressInd
Local ChaptersfalseLocalChaptersInd
Form990 Provided To Gvrn BodyYes (true)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (true)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (true)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (true)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (true)WhistleblowerPolicyInd
Document Retention PolicyYes (true)DocumentRetentionPolicyInd
Compensation Process CEOYes (true)CompensationProcessCEOInd
Compensation Process OtherYes (true)CompensationProcessOtherInd
Investment In Joint VenturefalseInvestmentInJointVentureInd
States Where Copy Of Return Is FldALStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldAKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldARStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCOStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldFLStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldGAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldHIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldILStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldLAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMEStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNJStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNMStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldORStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldPAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldRIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldSCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldTNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldUTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldVAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWVStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWIStatesWhereCopyOfReturnIsFldCd
Own WebsiteYes (X)OwnWebsiteInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

FieldValueIRS element (for citing)
PersonBRADLEY JENSENPersonNm
Phone2128061703PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1120 WALL STREET 13TH FLOORAddressLine1
Citynew yorkCity
StateNYState
ZIP Code100053908ZIPCode

Form990 Part VII Section A Form990PartVIISectionAGrp (42 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtKey EmployeeKeyEmployeeIndHighest Compensated EmployeeHighestCompensatedEmployeeIndFormer Ofcr Director TrusteeFormerOfcrDirectorTrusteeInd
Mathilde Krim PhD
Founding Chairman1.0Yes (X)Yes (X)$0$0$0
Kenneth Cole
Chairman of the Board1.0Yes (X)Yes (X)$0$0$0
Patricia J Matson
Vice Chairman1.0Yes (X)Yes (X)
John C Simons
Vice Chairman1.0Yes (X)Yes (X)
Wallace Sheft CPA
Treasurer1.0Yes (X)Yes (X)
Mervyn F Silverman MDMPH
Secretary1.0Yes (X)Yes (X)
Arlen H Andelson
Trustee1.0Yes (X)
Harry Belafonte
Trustee (NON-VOTING)1.0Yes (X)
David Bohnett
Trustee1.0Yes (X)
Zev Braun
Trustee (NON-VOTING)1.0Yes (X)
Jonathan S Canno
Trustee1.0Yes (X)
Donald Capoccia
Trustee1.0Yes (X)
R Martin Chavez PhD
Trustee1.0Yes (X)
Jane B Eisner
Trustee (NON-VOTING)1.0Yes (X)
T Ryan Greenawalt
Trustee1.0Yes (X)
Regan Hofmann
Trustee1.0Yes (X)
Michael J Klingensmith
Trustee1.0Yes (X)
Kevin McClatchy
Trustee1.0Yes (X)
Michele V McNeill PharmD
Trustee (NON-VOTING)1.0Yes (X)
Edward Milstein
Trustee1.0Yes (X)
Cindy Rachofsky
Trustee1.0Yes (X)
Vincent A Roberti
Trustee1.0Yes (X)
Bill Roedy
Trustee1.0Yes (X)
Raymond F Schinazi PhD
Trustee1.0Yes (X)
Alan D Schwartz
Trustee (NON-VOTING)1.0Yes (X)
Diana L Taylor
Trustee (NON-VOTING)1.0Yes (X)$0$0$0
Kevin Wendle
Trustee (NON-VOTING)1.0Yes (X)
Kevin Frost
Chief Executive Officer40.0Yes (X)$411,466$140,181
Bradley Jensen
Assistant Treasurer, Cfo40.0Yes (X)$225,977$51,151
John F Logan JD PhD
AssT Sec, Vp, GEN COUNSEL40.0Yes (X)$210,168$26,323
Rowena Johnston
AsSt Secretary, Vice PresIDENT40.0Yes (X)$173,783$23,624
Edward Donnelly
Asst Treasurer, ControlleR40.0Yes (X)$139,447$20,664
Eric Muscatell
Vice President of Development40.0$164,114$23,146Yes (X)
Christopher Collins
Vice President, Public Policy40.0$190,478$48,545Yes (X)
Annette Sohn
Vice President, TREAT Asia PGM40.0$200,792$20,081Yes (X)
AnnMarie Shannahan
Vice President, Public Info.40.0$200,861$25,569Yes (X)
Andrew McInness
Director, Publications40.0$142,695$45,333Yes (X)
Anthony Ancona
Vice President, Human Resource40.0$158,957$22,792Yes (X)
Susan Doster
Chief Technology Officer40.0$132,756$25,489Yes (X)
Bennah Serfaty
Sr Director of CommunicatiON40.0$113,800$43,226Yes (X)
Raoul Norman Tenazas
Creative Director40.0$110,187$43,099Yes (X)
GREGORY L BOROFF
VP, DEVELOPMENT40.0$155,189$17,649Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$2,730,670TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$576,872TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K18IndivRcvdGreaterThan100KCnt
Former Ofcr Employees ListedYes (true)FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (true)TotalCompGreaterThan150KInd
Compensation From Other SrcsfalseCompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1CityContractorAddress/USAddress/CityStateContractorAddress/USAddress/StateZIP CodeContractorAddress/USAddress/ZIPCodeServicesServicesDescCompensationCompensationAmt
Josh Woods Production
39 West 14th Street Suite 504NEW YORKNY10011events production$425,200
AAB Productions
64 allen street 5th floorNEW YORKNY10002Events Production$338,942
The Morris King Company LLC
101 Fifth Avenue 8th FloorNEW YORKNY10003public relations$162,000
Stamp Event Management LLC
247 Centre Street 7th FloorNEW YORKNY10013Events Production$124,418
Global Health Institute
5530 Wisconsin Avenue Suite 1255CHEVY CHASEMD20815consulting$120,000
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K7CntrctRcvdGreaterThan100KCnt
Federated Campaigns$376,242FederatedCampaignsAmt
Fundraising$39,937,861FundraisingAmt
Government Grants$7,391,835GovernmentGrantsAmt
All Other Contributions$9,850,578AllOtherContributionsAmt
Noncash Contributions$199,065NoncashContributionsAmt
Total Contributions$57,556,516TotalContributionsAmt
Total Program Service Revenue$0TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$740,190TotalRevenueColumnAmt
Exclusion$740,190ExclusionAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$64,176TotalRevenueColumnAmt
Exclusion$64,176ExclusionAmt

Rental Income Or Loss RentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Real$0RealAmt
Personal$0PersonalAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$17,316,472SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$16,831,197SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$485,275SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$485,275TotalRevenueColumnAmt
Exclusion$485,275ExclusionAmt
FieldValueIRS element (for citing)
Fundraising Gross Income$1,448,865FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event$39,937,861ContriRptFundraisingEventAmt
Fundraising Direct Expenses$12,639,445FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

FieldValueIRS element (for citing)
Total Revenue Column-$11,190,580TotalRevenueColumnAmt
Exclusion-$11,190,580ExclusionAmt

Net Income From Gaming NetIncomeFromGamingGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
FieldValueIRS element (for citing)
Gross Sales Of Inventory$239,927GrossSalesOfInventoryAmt

Net Income Or Loss NetIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$239,927TotalRevenueColumnAmt
Exclusion$239,927ExclusionAmt

Other Revenue Misc OtherRevenueMiscGrp (2 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtExclusionExclusionAmt
LIST RENTALS900099$3,116$3,116
MISCELLANEOUS INCOME900099$1,495$1,495
FieldValueIRS element (for citing)
Other Revenue Total$4,611OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$47,900,115TotalRevenueColumnAmt
Exclusion-$9,656,401ExclusionAmt
FieldValueIRS element (for citing)
Info In Schedule O Part IXYes (X)InfoInScheduleOPartIXInd

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$5,087,056TotalAmt
Program Services$5,087,056ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$4,841,328TotalAmt
Program Services$4,841,328ProgramServicesAmt

Benefits To Members BenefitsToMembersGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$2,289,885TotalAmt
Program Services$1,661,237ProgramServicesAmt
Management And General$305,219ManagementAndGeneralAmt
Fundraising$323,429FundraisingAmt

Comp Disqual Persons CompDisqualPersonsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$5,300,415TotalAmt
Program Services$3,564,555ProgramServicesAmt
Management And General$578,582ManagementAndGeneralAmt
Fundraising$1,157,278FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$312,266TotalAmt
Program Services$212,168ProgramServicesAmt
Management And General$38,939ManagementAndGeneralAmt
Fundraising$61,159FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$1,196,548TotalAmt
Program Services$775,429ProgramServicesAmt
Management And General$175,700ManagementAndGeneralAmt
Fundraising$245,419FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$483,745TotalAmt
Program Services$313,041ProgramServicesAmt
Management And General$61,023ManagementAndGeneralAmt
Fundraising$109,681FundraisingAmt

Fees For Services Management FeesForServicesManagementGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$142,109TotalAmt
Program Services$113,795ProgramServicesAmt
Management And General$22,025ManagementAndGeneralAmt
Fundraising$6,289FundraisingAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$206,660TotalAmt
Management And General$206,660ManagementAndGeneralAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$54,005TotalAmt
Program Services$54,005ProgramServicesAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

FieldValueIRS element (for citing)
Total$569,004TotalAmt
Fundraising$569,004FundraisingAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$181,719TotalAmt
Management And General$181,719ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$1,902,283TotalAmt
Program Services$1,373,365ProgramServicesAmt
Management And General$55,077ManagementAndGeneralAmt
Fundraising$473,841FundraisingAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$165,416TotalAmt
Program Services$158,464ProgramServicesAmt
Management And General$1,452ManagementAndGeneralAmt
Fundraising$5,500FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$70,568TotalAmt
Program Services$44,089ProgramServicesAmt
Management And General$7,134ManagementAndGeneralAmt
Fundraising$19,345FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$206,908TotalAmt
Program Services$146,402ProgramServicesAmt
Management And General$27,883ManagementAndGeneralAmt
Fundraising$32,623FundraisingAmt

Royalties RoyaltiesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$1,283,349TotalAmt
Program Services$886,297ProgramServicesAmt
Management And General$164,549ManagementAndGeneralAmt
Fundraising$232,503FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$1,193,970TotalAmt
Program Services$654,496ProgramServicesAmt
Management And General$4,914ManagementAndGeneralAmt
Fundraising$534,560FundraisingAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$834,225TotalAmt
Program Services$740,680ProgramServicesAmt
Management And General$12,908ManagementAndGeneralAmt
Fundraising$80,637FundraisingAmt

Interest InterestGrp

FieldValueIRS element (for citing)
Total$59TotalAmt
Management And General$59ManagementAndGeneralAmt

Payments To Affiliates PaymentsToAffiliatesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$324,970TotalAmt
Program Services$224,998ProgramServicesAmt
Management And General$41,773ManagementAndGeneralAmt
Fundraising$58,199FundraisingAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$251,444TotalAmt
Program Services$174,091ProgramServicesAmt
Management And General$32,322ManagementAndGeneralAmt
Fundraising$45,031FundraisingAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmtFundraisingFundraisingAmt
PROGRAM MATERIALS$3,328,092$3,328,092
POSTAGE & SHIPPING$801,242$371,668$5,081$424,493
PROGRAM TECHNICAL SUPPORT$947,234$947,234
PRINTING$670,672$222,662$525$447,485

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$1,747,952TotalAmt
Program Services$871,839ProgramServicesAmt
Management And General$548,936ManagementAndGeneralAmt
Fundraising$327,177FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$34,393,124TotalAmt
Program Services$26,766,991ProgramServicesAmt
Management And General$2,472,480ManagementAndGeneralAmt
Fundraising$5,153,653FundraisingAmt
FieldValueIRS element (for citing)
Joint CostsYes (X)JointCostsInd

Total Joint Costs TotalJointCostsGrp

FieldValueIRS element (for citing)
Total$1,012,168TotalAmt
Program Services$380,896ProgramServicesAmt
Fundraising$631,272FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$8,001,602BOYAmt
EOY$4,961,745EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$539,347BOYAmt
EOY$323,338EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$205,706BOYAmt
EOY$0EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$10,267,012BOYAmt
EOY$5,045,656EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

FieldValueIRS element (for citing)
BOY$133,906BOYAmt
EOY$213,295EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$1,401,620BOYAmt
EOY$1,475,828EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$5,731,579LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$3,500,879LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$1,975,311BOYAmt
EOY$2,230,700EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$23,656,458BOYAmt
EOY$40,982,916EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

FieldValueIRS element (for citing)
BOY$3,169,232BOYAmt
EOY$2,101,105EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Intangible Assets IntangibleAssetsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$674,143BOYAmt
EOY$561,388EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$50,024,337BOYAmt
EOY$57,895,971EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$1,688,090BOYAmt
EOY$2,132,495EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
BOY$2,200,512BOYAmt
EOY$2,547,120EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$13,321,993BOYAmt
EOY$7,166,426EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Escrow Account Liability EscrowAccountLiabilityGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$1,681,719BOYAmt
EOY$1,739,583EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$18,892,314BOYAmt
EOY$13,585,624EOYAmt
FieldValueIRS element (for citing)
Organization Follows SFAS117Yes (X)OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

FieldValueIRS element (for citing)
BOY$23,555,115BOYAmt
EOY$38,819,754EOYAmt

Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp

FieldValueIRS element (for citing)
BOY$7,236,209BOYAmt
EOY$5,143,351EOYAmt

Permanently Rstr Net Assets PermanentlyRstrNetAssetsGrp

FieldValueIRS element (for citing)
BOY$340,699BOYAmt
EOY$347,242EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$31,132,023BOYAmt
EOY$44,310,347EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$50,024,337BOYAmt
EOY$57,895,971EOYAmt
FieldValueIRS element (for citing)
Info In Schedule O Part XIYes (X)InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss$13,506,991ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst-$295,064NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets-$33,603OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or ReviewfalseAccountantCompileOrReviewInd
FS AuditedYes (true)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Separate Basis Fincl StmtYes (X)SeparateBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (true)AuditCommitteeInd
Federal Grant Audit RequiredYes (true)FederalGrantAuditRequiredInd
Federal Grant Audit PerformedYes (true)FederalGrantAuditPerformedInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$22,553,697CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$22,876,129CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$33,247,849CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$38,582,579CurrentTaxYearMinus1YearAmt
Current Tax Year$57,556,516CurrentTaxYearAmt
Total$174,816,770TotalAmt

Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$22,553,697CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$22,876,129CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$33,247,849CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$38,582,579CurrentTaxYearMinus1YearAmt
Current Tax Year$57,556,516CurrentTaxYearAmt
Total$174,816,770TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$4,735,381SubstantialContributorsTotAmt
Public Support Total170$170,081,389PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$668,573CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$951,963CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$897,974CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$755,293CurrentTaxYearMinus1YearAmt
Current Tax Year$804,366CurrentTaxYearAmt
Total$4,078,169TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$2,756,152CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$1,735,330CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$1,624,966CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$1,467,184CurrentTaxYearMinus1YearAmt
Current Tax Year$1,693,403CurrentTaxYearAmt
Total$9,277,035TotalAmt
FieldValueIRS element (for citing)
Total Support$188,171,974TotalSupportAmt
Gross Receipts Rltd Activities$0GrossReceiptsRltdActivitiesAmt
Public Support CY1700.90386PublicSupportCY170Pct
Public Support PY1700.93372PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule C IRS990ScheduleC

FieldValueIRS element (for citing)
Total Grassroots LobbyingTotalGrassrootsLobbyingGrp
Total Direct LobbyingTotalDirectLobbyingGrp
Total Lobbying ExpendTotalLobbyingExpendGrp
Other Exempt Purpose ExpendOtherExemptPurposeExpendGrp
Total Exempt Purpose ExpendTotalExemptPurposeExpendGrp
Lobbying Nontaxable AmountLobbyingNontaxableAmountGrp
Grassroots NontaxableGrassrootsNontaxableGrp
Tot Lbbyng Grassroot Mns Non TxTotLbbyngGrassrootMnsNonTxGrp
Tot Lbby Expend Mns Lbbyng Non TxTotLbbyExpendMnsLbbyngNonTxGrp
VolunteersfalseVolunteersInd
Paid Staff Or ManagementYes (true)PaidStaffOrManagementInd
Media AdvertisementsfalseMediaAdvertisementsInd
Mailings MembersfalseMailingsMembersInd
Publications Or BroadcastfalsePublicationsOrBroadcastInd
Grants Other OrganizationsfalseGrantsOtherOrganizationsInd
Direct Contact LegislatorsfalseDirectContactLegislatorsInd
Rallies DemonstrationsfalseRalliesDemonstrationsInd
Other ActivitiesYes (true)OtherActivitiesInd
Other Activities$179,298OtherActivitiesAmt
Total Lobbying Expenditures$179,298TotalLobbyingExpendituresAmt
Not Described Section501c3falseNotDescribedSection501c3Ind
Form4720 Filed4912 TaxfalseForm4720Filed4912TaxInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceLobbying ExpensesFormAndLineReferenceDesc
ExplanationPart II-B The Foundation for AIDS Research developed an Action Agenda to End AIDS that identified critical decisions that need to be made to advance evidence based AIDS policies. We created a variety of issue briefs on topics such as the potential impact of various budget scenarios on global health services, and policy priorities to address the HIV epidemic among gay men in the US. These issue briefs were shared with Capitol Hill staff and members of the Administration. amfAR met regularly with staff to members of Congress and with Administration staff, and we provided input to the Administration on development of the PEPFAR Blueprint for an AIDS Free Generation. amfAR sponsored several briefings on Capitol Hill on AIDS policy and research issues. amfAR uses these briefings as an educational tool.ExplanationTxt

Schedule D IRS990ScheduleD

Art Public Exhibition Amounts ArtPublicExhibitionAmountsGrp

FieldValueIRS element (for citing)
Assets Included$238,050AssetsIncludedAmt
FieldValueIRS element (for citing)
Held Works ArtHeldWorksArtGrp

Collection Used Other Purposes CollectionUsedOtherPurposesGrp

FieldValueIRS element (for citing)
Collection Used Other PurposesYes (X)CollectionUsedOtherPurposesInd
Other PurposesDonated Items, Inventory etc.OtherPurposesDesc
FieldValueIRS element (for citing)
Solicited Assets SaleYes (true)SolicitedAssetsSaleInd

CY Endwmt Fund CYEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$443,886BeginningYearBalanceAmt
Contributions$6,543ContributionsAmt
Investment Earnings Or Losses$40,550InvestmentEarningsOrLossesAmt
End Year Balance$490,979EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$520,804BeginningYearBalanceAmt
Contributions$3,211ContributionsAmt
Investment Earnings Or Losses$20,742InvestmentEarningsOrLossesAmt
Other Expenditures$100,871OtherExpendituresAmt
End Year Balance$443,886EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$464,356BeginningYearBalanceAmt
Contributions$4,341ContributionsAmt
Investment Earnings Or Losses$52,107InvestmentEarningsOrLossesAmt
End Year Balance$520,804EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$561,083BeginningYearBalanceAmt
Contributions$5,978ContributionsAmt
Investment Earnings Or Losses-$2,705InvestmentEarningsOrLossesAmt
Other Expenditures$100,000OtherExpendituresAmt
End Year Balance$464,356EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$516,826BeginningYearBalanceAmt
Contributions$8,258ContributionsAmt
Investment Earnings Or Losses$35,999InvestmentEarningsOrLossesAmt
End Year Balance$561,083EndYearBalanceAmt
FieldValueIRS element (for citing)
Prmnnt Endowment Balance EOY0.70724PrmnntEndowmentBalanceEOYPct
Term Endowment Balance EOY0.29276TermEndowmentBalanceEOYPct
Endowments Held Unrelated OrgfalseEndowmentsHeldUnrelatedOrgInd
Endowments Held Related OrgfalseEndowmentsHeldRelatedOrgInd
LandLandGrp
BuildingsBuildingsGrp

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$2,210,687OtherCostOrOtherBasisAmt
Depreciation$757,960DepreciationAmt
Book Value$1,452,727BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$309,029OtherCostOrOtherBasisAmt
Depreciation$264,410DepreciationAmt
Book Value$44,619BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$3,211,863OtherCostOrOtherBasisAmt
Depreciation$2,478,509DepreciationAmt
Book Value$733,354BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$2,230,700TotalBookValueLandBuildingsAmt
Federal Income Tax Liability$0FederalIncomeTaxLiabilityAmt

Other Liabilities Org OtherLiabilitiesOrgGrp (2 entries)

DescDescAmtAmt
LONG TERM LEASE LIABILITY$1,526,258
SECTION 457 RETIREMENT LIABILITIES$213,325
FieldValueIRS element (for citing)
Total Liability$1,739,583TotalLiabilityAmt
Footnote TextYes (X)FootnoteTextInd
Total Rev Etc Audited Fincl Stmt$47,761,076TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst-$295,064NetUnrealizedGainsInvstAmt
Donated Services And Use Fclts$189,628DonatedServicesAndUseFcltsAmt
Other Revenue-$33,603OtherRevenueAmt
Revenue Not Reported-$139,039RevenueNotReportedAmt
Revenue Subtotal$47,900,115RevenueSubtotalAmt
Total Revenue Per Form990$47,900,115TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$34,582,752TotExpnsEtcAuditedFinclStmtAmt
Donated Services Use Fclts$189,628DonatedServicesUseFcltsAmt
Expenses Not Reported$189,628ExpensesNotReportedAmt
Expenses Subtotal$34,393,124ExpensesSubtotalAmt
Total Expenses Per Form990$34,393,124TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (4 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
EndowmentsPart V, Line 4 AMFAR's endowment fund is intended to fund the various general research programs the organization sponsors.
FIN 48Income taxes Amfar follows guidance that clarifies the accounting for uncertainty in tax positions taken or expected to be taken in a tax return, including issues relating to financial statement recognition and guidance on measurement, classification, interest and penalties, and disclosure. As of September 30, 2014, amfar does not believe that there are any uncertain tax positions within its financial statements. Amfar has processes presently in place to ensure the maintenance of its tax-exempt status; to identify and report unrelated income; to determine its filing and tax obligations in jurisdictions for which it has nexus; and to identify and evaluate other matters that may be considered tax positions. The tax years ended 2011, 2012, 2013, and 2014 are still open to audit for both federal and state purposes.
reconciliation of revenuepart XI, Line 2d change in value for third party trust ($33,603)
Collections of Art, Historical Treasures, or other similar assetsPart III, Line 4 AMFAR holds various items of jewelry, photographs and other items of artistic value that have been donated to the organization for sale at special events. The organization has maintained these items in inventory for a few years and is in the process of selling them.

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records MaintainedYes (true)GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (13 entries)

RegionRegionTxtType Of Activities ConductedTypeOfActivitiesConductedTxtSpecific Services ProvidedSpecificServicesProvidedTxtRegion Total ExpendituresRegionTotalExpendituresAmtOfficesOfficesCntEmployeeEmployeeCnt
Central America and the CaribbeanGrantmakingN/A$74,955
East Asia and the PacificProgram ServicesTHERAPEUTICS RESEARCH$2,186,834119
Europe (Including Iceland and Greenland)Fundraisingn/a$14,863,143
North AmericaGrantmakingn/a$266,518
Russia and the Newly Independent StatesGrantmakingn/a$25,000
South AmericaFundraisingn/a$1,687,171
South AsiaFundraisingn/a$1,044,280
Sub-Saharan AfricaGrantmakingn/a$254,310
East Asia and the PacificGrantmakingn/a$3,063,980
Europe (Including Iceland and Greenland)Grantmakingn/a$824,303
North AmericaFundraisingn/a$1,791
South AmericaGrantmakingn/a$189,805
South AsiaGrantmakingn/a$142,457
FieldValueIRS element (for citing)
Subtotal Offices1SubtotalOfficesCnt
Subtotal Employees19SubtotalEmployeesCnt
Total Office1TotalOfficeCnt
Total Employee19TotalEmployeeCnt
Subtotal Spent$24,624,547SubtotalSpentAmt
Total Spent$24,624,547TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (149 entries)

RegionRegionTxtPurpose Of GrantPurposeOfGrantTxtCash GrantCashGrantAmtManner Of Cash DisbursementMannerOfCashDisbursementTxt
Caribbean/Central AmericaGMT INITIATIVES$10,000wire transfe
Caribbean/Central AmericaGMT INITIATIVES$19,955wire transfe
Caribbean/Central AmericaGMT INITIATIVES$20,000wire transfe
Caribbean/Central AmericaGMT INITIATIVES$25,000wire transfe
East Asia/PacificTREAT ASIA$5,050wire transfe
East Asia/PacificTREAT ASIA$5,175wire transfe
East Asia/PacificTREAT ASIA$5,175wire transfe
East Asia/PacificTREAT ASIA$5,250wire transfe
East Asia/PacificTREAT ASIA$5,625wire transfe
East Asia/PacificTREAT ASIA$5,625wire transfe
East Asia/PacificTREAT ASIA$5,625wire transfe
East Asia/PacificTREAT ASIA$5,625wire transfe
East Asia/PacificTREAT ASIA$5,625wire transfe
East Asia/PacificTREAT ASIA$5,845wire transfe
East Asia/PacificTREAT ASIA$5,915wire transfe
East Asia/PacificTREAT ASIA$5,948wire transfe
East Asia/PacificTREAT ASIA$5,990wire transfe
East Asia/PacificTREAT ASIA$6,000wire transfe
East Asia/PacificTREAT ASIA$6,075wire transfe
East Asia/PacificTREAT ASIA$6,600wire transfe
East Asia/PacificTREAT ASIA$6,700wire transfe
East Asia/PacificTREAT ASIA$6,825wire transfe
East Asia/PacificTREAT ASIA$7,500wire transfe
East Asia/PacificTREAT ASIA$7,500wire transfe
East Asia/PacificTREAT ASIA$7,500wire transfe
East Asia/PacificTREAT ASIA$7,545wire transfe
East Asia/PacificTREAT ASIA$7,865wire transfe
East Asia/PacificTREAT ASIA$7,898wire transfe
East Asia/PacificTREAT ASIA$8,000wire transfe
East Asia/PacificTREAT ASIA$8,135wire transfe
East Asia/PacificTREAT ASIA$8,500wire transfe
East Asia/PacificTREAT ASIA$8,960wire transfe
East Asia/PacificTREAT ASIA$9,253wire transfe
East Asia/PacificTREAT ASIA$9,383wire transfe
East Asia/PacificTREAT ASIA$11,250wire transfe
East Asia/PacificTREAT ASIA$11,250wire transfe
East Asia/PacificTREAT ASIA$11,250wire transfe
East Asia/PacificTREAT ASIA$11,787wire transfe
East Asia/PacificTREAT ASIA$12,020wire transfe
East Asia/PacificTREAT ASIA$12,220wire transfe
East Asia/PacificTREAT ASIA$12,500wire transfe
East Asia/PacificTREAT ASIA$12,510wire transfe
East Asia/PacificTREAT ASIA$12,900wire transfe
East Asia/PacificTREAT ASIA$13,270wire transfe
East Asia/PacificTREAT ASIA$13,500wire transfe
East Asia/PacificTREAT ASIA$13,500wire transfe
East Asia/PacificTREAT ASIA$13,593wire transfe
East Asia/PacificTREAT ASIA$14,850wire transfe
East Asia/PacificTREAT ASIA$14,873wire transfe
East Asia/PacificTREAT ASIA$15,000wire transfe
East Asia/PacificTREAT ASIA$15,065wire transfe
East Asia/PacificTREAT ASIA$15,100wire transfe
East Asia/PacificTREAT ASIA$15,150wire transfe
East Asia/PacificTREAT ASIA$15,500wire transfe
East Asia/PacificTREAT ASIA$15,600wire transfe
East Asia/PacificTREAT ASIA$15,830wire transfe
East Asia/PacificTREAT ASIA$17,330wire transfe
East Asia/PacificTREAT ASIA$18,486wire transfe
East Asia/PacificTREAT ASIA$18,750wire transfe
East Asia/PacificTREAT ASIA$19,150wire transfe
East Asia/PacificTREAT ASIA$19,200wire transfe
East Asia/PacificTREAT ASIA$19,574wire transfe
East Asia/PacificTREAT ASIA$19,780wire transfe
East Asia/PacificTREAT ASIA$20,000wire transfe
East Asia/PacificTREAT ASIA$20,000wire transfe
East Asia/PacificTREAT ASIA$20,000wire transfe
East Asia/PacificTREAT ASIA$20,000wire transfe
East Asia/PacificTREAT ASIA$20,000wire transfe
East Asia/PacificTREAT ASIA$20,000wire transfe
East Asia/PacificTREAT ASIA$20,000wire transfe
East Asia/PacificTREAT ASIA$20,000wire transfe
East Asia/PacificTREAT ASIA$20,923wire transfe
East Asia/PacificGMT INITIATIVES$25,000wire transfe
East Asia/PacificGMT INITIATIVES$25,000wire transfe
East Asia/PacificGMT INITIATIVES$25,000wire transfe
East Asia/PacificTREAT ASIA$25,000wire transfe
East Asia/PacificTREAT ASIA$25,200wire transfe
East Asia/PacificTREAT ASIA$26,850wire transfe
East Asia/PacificTREAT ASIA$29,515wire transfe
East Asia/PacificTREAT ASIA$30,024wire transfe
East Asia/PacificTREAT ASIA$31,388wire transfe
East Asia/PacificTREAT ASIA$32,175wire transfe
East Asia/PacificTREAT ASIA$32,515wire transfe
East Asia/PacificTREAT ASIA$33,010wire transfe
East Asia/PacificTREAT ASIA$33,010wire transfe
East Asia/PacificTREAT ASIA$34,010wire transfe
East Asia/PacificTREAT ASIA$34,035wire transfe
East Asia/PacificTREAT ASIA$35,000wire transfe
East Asia/PacificTREAT ASIA$35,000wire transfe
East Asia/PacificTREAT ASIA$41,158wire transfe
East Asia/PacificTREAT ASIA$46,905wire transfe
East Asia/PacificGMT INITIATIVES$50,000wire transfe
East Asia/PacificTREAT ASIA$50,000wire transfe
East Asia/PacificTREAT ASIA$54,000wire transfe
East Asia/PacificTREAT ASIA$57,276wire transfe
East Asia/PacificTREAT ASIA$75,579wire transfe
East Asia/PacificTREAT ASIA$75,717wire transfe
East Asia/PacificTREAT ASIA$77,250wire transfe
East Asia/PacificTREAT ASIA$95,000wire transfe
East Asia/PacificTREAT ASIA$104,839wire transfe
East Asia/PacificTREAT ASIA$110,570wire transfe
East Asia/PacificBASIC RESEARCH$120,000wire transfe
East Asia/PacificTREAT ASIA$192,418wire transfe
East Asia/PacificTREAT ASIA$221,907wire transfe
East Asia/PacificTREAT ASIA$227,908wire transfe
East Asia/PacificTREAT ASIA$232,676wire transfe
EuropeBASIC RESEARCH$39,066wire transfe
EuropePUBLIC POLICY$39,948wire transfe
EuropePUBLIC POLICY$50,000wire transfe
EuropeBASIC RESEARCH$60,000wire transfe
EuropeBASIC RESEARCH$60,000wire transfe
EuropeBASIC RESEARCH$75,000wire transfe
EuropeBASIC RESEARCH$75,000wire transfe
EuropeBASIC RESEARCH$75,635wire transfe
EuropeBASIC RESEARCH$81,852wire transfe
EuropeBASIC RESEARCH$120,000wire transfe
EuropeBASIC RESEARCH$147,802wire transfe
North America (excl USA)GMT INITIATIVES$18,000wire transfe
North America (excl USA)BASIC RESEARCH$118,518wire transfe
North America (excl USA)PREVENTION SCIENCE OUTREACH$130,000wire transfe
Russia/Newly Independent StatesGMT INITIATIVES$25,000wire transfe
South AmericaGMT INITIATIVES$19,885wire transfe
South AmericaGMT INITIATIVES$19,940wire transfe
South AmericaGMT INITIATIVES$19,980wire transfe
South AmericaGMT INITIATIVES$20,000wire transfe
South AmericaGMT INITIATIVES$20,000wire transfe
South AmericaGMT INITIATIVES$20,000wire transfe
South AmericaPREVENTION SCIENCE OUTREACH$20,000wire transfe
South AmericaPREVENTION SCIENCE OUTREACH$50,000wire transfe
South AsiaTREAT ASIA$5,625wire transfe
South AsiaTREAT ASIA$7,500wire transfe
South AsiaTREAT ASIA$8,000wire transfe
South AsiaTREAT ASIA$11,793wire transfe
South AsiaTREAT ASIA$19,400wire transfe
South AsiaTREAT ASIA$19,542wire transfe
South AsiaTREAT ASIA$20,000wire transfe
South AsiaTREAT ASIA$31,631wire transfe
Sub-Saharan AfricaGMT INITIATIVES$12,000wire transfe
Sub-Saharan AfricaGMT INITIATIVES$12,310wire transfe
Sub-Saharan AfricaGMT INITIATIVES$20,000wire transfe
Sub-Saharan AfricaGMT INITIATIVES$20,000wire transfe
Sub-Saharan AfricaGMT INITIATIVES$20,000wire transfe
Sub-Saharan AfricaGMT INITIATIVES$20,000wire transfe
Sub-Saharan AfricaGMT INITIATIVES$20,000wire transfe
Sub-Saharan AfricaGMT INITIATIVES$20,000wire transfe
Sub-Saharan AfricaGMT INITIATIVES$25,000wire transfe
Sub-Saharan AfricaGMT INITIATIVES$25,000wire transfe
Sub-Saharan AfricaGMT INITIATIVES$25,000wire transfe
Sub-Saharan AfricaPUBLIC POLICY$25,000wire transfe
FieldValueIRS element (for citing)
Total501c3 Org149Total501c3OrgCnt
Transfer To Foreign CorpfalseTransferToForeignCorpInd
Interest In Foreign TrustfalseInterestInForeignTrustInd
Foreign Corp OwnershipfalseForeignCorpOwnershipInd
Passive Foreign Investmest CofalsePassiveForeignInvestmestCoInd
Foreign PartnershipfalseForeignPartnershipInd
Boycott CountriesfalseBoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Foreign ActivitiesPart I, Line 2 International organizations are recommended for funding based upon the results of community-based peer review and/or program staff assessment of proposal merit and organization capacity to undertake proposed projects that are CHARITABLE in purpose. Pre-award due-diligence for new international grantees includes review of organization documents and registrations to verify that the organization operates for a CHARITABLE purpose and that basic capacity for project oversight and governance has been established. All international grantees are required to report semi-annually on project progress and expenditures; continued reporting is required until such time as grant funds are expended in full. Reports are reviewed by administrative and program staff. Additional oversight is provided as necessary by means of ongoing, informal contact with sites regarding progress and technical issues and site visits where feasible. International research grant recipients submit an interim and a final progress reporting addition to expenditures reports due following the ends of the 2nd, 3rd and final quarters of the performance period.
foreign activitiesPart I, Line 3, Column D The Foundation for AIDS Research conducts many of its grant-making program services (see Part III of Form 990) in U.S. and foreign jurisdictions. In column D, the organization has reported the basic program these grants support; please refer to Part III for more information about these programs/initiatives.
Foreign Activities - Status of GranteesThe Foundation for Aids Research supports many non-U.S. organizations in the fight against AIDS and HIV-related diseases. For purposes of Schedule F, Part II, Line 2 - all 149 charities supported are presumed to be the equivalent of U.S. charities.

Schedule G IRS990ScheduleG

FieldValueIRS element (for citing)
Mail SolicitationsYes (X)MailSolicitationsInd
Email SolicitationsYes (X)EmailSolicitationsInd
Phone SolicitationsYes (X)PhoneSolicitationsInd
Solicitation Of Non Govt GrantsYes (X)SolicitationOfNonGovtGrantsInd
Solicitation Of Govt GrantsYes (X)SolicitationOfGovtGrantsInd
Special Fundraising EventsYes (X)SpecialFundraisingEventsInd
Agrmt Prof Fundraising ActyYes (true)AgrmtProfFundraisingActyInd

Fundraiser Activity Info FundraiserActivityInfoGrp (4 entries)

Address Line1USAddress/AddressLine1Address Line2USAddress/AddressLine2CityUSAddress/CityStateUSAddress/StateZIP CodeUSAddress/ZIPCodeActivityActivityTxtFundraiser Control Of FundsFundraiserControlOfFundsIndGross ReceiptsGrossReceiptsAmtRetained By ContractorRetainedByContractorAmtNet To OrganizationNetToOrganizationAmt
aab productions
387 GRANT STREETSUITE K705NEW YORKNY10002events productionfalse$31,238,437$555,619$30,682,818
EIDOLON COMMUNICATIONS INC
15 MAIDEN LANE SUITE 1401NEW YORKNY10038direct mailfalse$2,023,625$228,493$1,795,132
public interest communications
7700 LEESBURG PIKEFALLS CHURCHVA22043tele marketingfalse$14,927$39,032-$24,105
SANKY COMMUNICATIONS INC
589 EIGHT AVENUE 10TH FLOORNEW YORKNY10018TELE MARKETINGfalse$353,939$57,810$296,129
FieldValueIRS element (for citing)
Total Gross Receipts$33,630,928TotalGrossReceiptsAmt
Total Retained By Contractors$880,954TotalRetainedByContractorsAmt
Total Net To Organization$32,749,974TotalNetToOrganizationAmt
Licensed StatesALLicensedStatesCd
Licensed StatesAKLicensedStatesCd
Licensed StatesARLicensedStatesCd
Licensed StatesCALicensedStatesCd
Licensed StatesCOLicensedStatesCd
Licensed StatesCTLicensedStatesCd
Licensed StatesDCLicensedStatesCd
Licensed StatesFLLicensedStatesCd
Licensed StatesGALicensedStatesCd
Licensed StatesHILicensedStatesCd
Licensed StatesILLicensedStatesCd
Licensed StatesKSLicensedStatesCd
Licensed StatesKYLicensedStatesCd
Licensed StatesLALicensedStatesCd
Licensed StatesMELicensedStatesCd
Licensed StatesMDLicensedStatesCd
Licensed StatesMALicensedStatesCd
Licensed StatesMILicensedStatesCd
Licensed StatesMNLicensedStatesCd
Licensed StatesMSLicensedStatesCd
Licensed StatesMOLicensedStatesCd
Licensed StatesNVLicensedStatesCd
Licensed StatesNHLicensedStatesCd
Licensed StatesNJLicensedStatesCd
Licensed StatesNMLicensedStatesCd
Licensed StatesNYLicensedStatesCd
Licensed StatesNCLicensedStatesCd
Licensed StatesNDLicensedStatesCd
Licensed StatesOHLicensedStatesCd
Licensed StatesOKLicensedStatesCd
Licensed StatesORLicensedStatesCd
Licensed StatesPALicensedStatesCd
Licensed StatesRILicensedStatesCd
Licensed StatesSCLicensedStatesCd
Licensed StatesTNLicensedStatesCd
Licensed StatesTXLicensedStatesCd
Licensed StatesUTLicensedStatesCd
Licensed StatesVALicensedStatesCd
Licensed StatesWALicensedStatesCd
Licensed StatesWVLicensedStatesCd
Licensed StatesWILicensedStatesCd

Fundraising Event Information FundraisingEventInformationGrp

FieldValueIRS element (for citing)
Name Of Event1CANNESNameOfEvent1Amt
Gross Receipts Event1$24,869,711GrossReceiptsEvent1Amt
Charitable Contri Event1$24,424,711CharitableContriEvent1Amt
Gross Revenue Event1$445,000GrossRevenueEvent1Amt
Rent Facility Costs Event1$1,333,994RentFacilityCostsEvent1Amt
Food And Beverage Event1$238,238FoodAndBeverageEvent1Amt
Entertainment Event1$1,218,319EntertainmentEvent1Amt
Other Direct Expenses Event1$3,748,981OtherDirectExpensesEvent1Amt
Name Of Event2DALLASNameOfEvent2Amt
Gross Receipts Event2$3,074,959GrossReceiptsEvent2Amt
Charitable Contri Event2$2,966,759CharitableContriEvent2Amt
Gross Revenue Event2$108,200GrossRevenueEvent2Amt
Rent Facility Costs Event2$283,704RentFacilityCostsEvent2Amt
Food And Beverage Event2$178,033FoodAndBeverageEvent2Amt
Entertainment Event2$84,797EntertainmentEvent2Amt
Other Direct Expenses Event2$481,108OtherDirectExpensesEvent2Amt
Other Events Total17OtherEventsTotalCnt
Gross Receipts Other Events$13,442,056GrossReceiptsOtherEventsAmt
Charitable Contri Other Events$12,546,391CharitableContriOtherEventsAmt
Gross Revenue Other Events$895,665GrossRevenueOtherEventsAmt
Rent Fclty Costs Other Events$348,100RentFcltyCostsOtherEventsAmt
Food And Beverage Other Events$641,481FoodAndBeverageOtherEventsAmt
Entertainment Other Events$1,804,451EntertainmentOtherEventsAmt
Oth Direct Expnss Other Events$2,278,239OthDirectExpnssOtherEventsAmt
Gross Receipts Total$41,386,726GrossReceiptsTotalAmt
Charitable Contributions Tot$39,937,861CharitableContributionsTotAmt
Gross Revenue Total Events$1,448,865GrossRevenueTotalEventsAmt
Rent Fclty Costs Total Events$1,965,798RentFcltyCostsTotalEventsAmt
Food And Beverage Total Events$1,057,752FoodAndBeverageTotalEventsAmt
Entertainment Total Events$3,107,567EntertainmentTotalEventsAmt
Oth Direct Expnss Total Events$6,508,328OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events$12,639,445DirectExpenseSummaryEventsAmt
Net Income Summary-$11,190,580NetIncomeSummaryAmt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSchedule G, Part IFormAndLineReferenceDesc
ExplanationThe Foundation for AIDS Research actually paid out $569,004 in fundraising expenses for the year ending September 30, 2014. This amount is reported on Part IX, Line 11(e). For purposes of Schedule G, the Foundation is reporting all amounts paid to the consultants listed on Part I, regardless of whether such amounts were pure fundraising expenses or event production costs. On Schedule G, the total amount paid to the organizations listed is $880,954. Of that $880,954, only $569,004 was paid for fundraising services, the remaining $311,950 was paid for event production services. In the interests of clarity, the foundation would also like to make clear that the compensation reported as having been paid to the professional fundraisers reported on Schedule G is reported on a fiscal year basis. Some of those same fundraisers are reported on the foundation's top 5 highest paid independent contractors list (in Schedule O). In compliance with the instructions to the Form 990, compensation reported for Part VII (and listed in Schedule O) is reported on a calendar year basis. Accordingly, amounts on Part VII and Schedule G will not reconcile.ExplanationTxt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (true)GrantRecordsMaintainedInd

Recipient Table RecipientTable (63 entries)

Address Line1USAddress/AddressLine1CityUSAddress/CityStateUSAddress/StateZIP CodeUSAddress/ZIPCodeRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtPurpose Of GrantPurposeOfGrantTxt
Vaccine & Gene Therapy Institute of Florida
11350 SW Village PkwyPt St LucieFL34987364631835501(c)(3)$5,209BASIC RESEARCH
University of Washington
4333 Brooklyn AvenueSeattleWA981959472916001537501(c)(3)$5,209BASIC RESEARCH
Vaccine & Gene Therapy Institute of Florida
11350 SW Village PkwyPt St LucieFL34987364631835501(c)(3)$5,209BASIC RESEARCH
Case Western Reserve University
10900 Euclid AveClevelandOH44106341018992501(c)(3)$5,209BASIC RESEARCH
AIDS Foundation of Chicago
200 West Jackson Ste 2200ChicagoIL60606363412054501(c)(3)$10,000MSM INITIATIVES
AIDS Project Los Angeles (APLA)
611 S Kingsley DriveLos AngelesCA90005953842506501(c)(3)$10,000MSM INITIATIVES
Case Western Reserve University
10900 Euclid AveClevelandOH44106341018992501(c)(3)$15,620BASIC RESEARCH
Aaron Diamond AIDS Research Center
455 1st Ave 7th FlNew YorkNY10016133540234501(c)(3)$15,626BASIC RESEARCH
New England Primate Research Center
Harvard Medical School 25 ShattuckSouthboroughMA01772042103580501(c)(3)$15,626BASIC RESEARCH
AIDS Resource Center Ohio
15 W 4th St No 200DaytonOH45402311126780501(c)(3)$20,000PUBLIC POLICY
AIDS Foundation of Chicago
200 W Jackson Ste 2200ChicagoIL60606363412054501(c)(3)$20,000PUBLIC POLICY
Baron Edmond de Rothschild Chemical Dep
1st Ave at 16th StNew YorkNY10003135564930501(c)(3)$22,500PUBLIC POLICY
John Hopkins University
733 N BroadwayBaltimoreMD21205520595110501(c)(3)$26,458TREAT ASIA
California Institute of Technology
1200 E California BlvdPasadenaCA91125951643307501(c)(3)$41,600BASIC RESEARCH
Case Western Reserve University
10900 Euclid AvenueClevelandOH44106341018992501(c)(3)$41,666BASIC RESEARCH
Massachusetts General Hospital
55 Fruit StreetBostonMA02114042697983501(c)(3)$41,666BASIC RESEARCH
The University of North Carolina at Chapel Hill
104 Airport DrChapel HillNC27599566001393501(c)(3)$43,754BASIC RESEARCH
Emory University
1599 Clifton RdAtlantaGA303224250580566256501(c)(3)$45,000BASIC RESEARCH
John Hopkins University
733 N BroadwayBaltimoreMD21205520595110501(c)(3)$45,571MSM INITIATIVES
Research Foundation for Mental Hygiene Inc
1015 Riverside DriveNew YorkNY10032141410842501(c)(3)$50,000MSM INITIATIVES
Black AIDS Institute
1833 West 8th StLos AngelesCA90057954742741501(c)(3)$50,000PUBLIC POLICY
Beth Israel Deaconess Medical Center
330 Brookline AvenueBostonMA02215042103881501(c)(3)$50,361BASIC RESEARCH
New Hope for Cambodian Children
PO Box 2490KilleenTX76549205301015501(c)(3)$53,790TREAT ASIA
Harvard Medical School
25 Shattuck StreetSouthboroughMA01772042697981501(c)(3)$59,600BASIC RESEARCH
Vaccine & Gene Therapy Institute of Florida
9801 SW Discovery WayPt St LucieFL34987364631835501(c)(3)$59,994BASIC RESEARCH
John Hopkins University School of Medicine
733 N BroadwayBaltimoreMD21205520595110501(c)(3)$59,999BASIC RESEARCH
Veterans Medical Research Foundation
3350 La Jolla Village Drive mc 151San DiegoCA92161330189397501(c)(3)$60,000BASIC RESEARCH
University of Washington
4333 Brooklyn Ave NESeattleWA98195916001537501(c)(3)$60,000BASIC RESEARCH
Fred Hutchinson Cancer Research Center
1100 Fairview Ave NSeattleWA98109237156071501(c)(3)$62,502BASIC RESEARCH
Dana-Farber Cancer Institute Inc
450 Brookline AveBostonMA02215042263040501(c)(3)$62,502BASIC RESEARCH
The Scripps Research Institute
10550 N Torrey Pines RdLa JollaCA92037330435954501(c)(3)$62,502BASIC RESEARCH
Colorado State University
408 Uni Svcs CtrFort CollinsCO80523846000545501(c)(3)$62,709BASIC RESEARCH
Oregon Health and Science University
3181 SW Sam Jackson rdPortlandOR97239193176109501(c)(3)$66,527BASIC RESEARCH
Mount Sinai Beth Israel
1st Ave at 16th StNew YorkNY10003135564934501(c)(3)$67,500PUBLIC POLICY
Vaccine & Gene Therapy Institute of Florida
9801 SW Discovery WayPt St LucieFL34987364631835501(c)(3)$74,940BASIC RESEARCH
Emory University
954 Gatewood Road NEAtlantaGA30329580566256501(c)(3)$75,000BASIC RESEARCH
Massachusetts General Hospital
55 Fruit StreetBostonMA02114042697983501(c)(3)$75,000BASIC RESEARCH
The University of North Carolina at Chapel Hill
104 Airport DrChapel HillNC27599566001393501(c)(3)$75,000BASIC RESEARCH
University of California Los Angeles
11000 Kinross AveLos AngelesCA90095956006143501(c)(3)$75,000BASIC RESEARCH
University of Southern California
2001 North Soto StLos AngelesCA90089951642394501(c)(3)$90,000BASIC RESEARCH
Emory University
1599 Clifton RdAtlantaGA303224250580566256501(c)(3)$90,000BASIC RESEARCH
Icahn School of Medicine at Mount Sinai
One Gustave Levy PlaceNew YorkNY10029136171197501(c)(3)$90,000BASIC RESEARCH
John Hopkins University
733 N BroadwayBaltimoreMD21205520595110501(c)(3)$90,000BASIC RESEARCH
John Hopkins University
733 N BroadwayBaltimoreMD21205520595110501(c)(3)$117,555BASIC RESEARCH
Oregon Health and Science University
3181 SW Sam Jackson RdPortlandOR97239931176109501(c)(3)$119,864BASIC RESEARCH
Vaccine & Gene Therapy Institute of Florida
9801 SW Discovery WayPt St LucieFL34987364631835501(c)(3)$119,957BASIC RESEARCH
Oregon Health and Science University
3181 SW Sam Jackson RdPortlandOR97239931176109501(c)(3)$119,994BASIC RESEARCH
John Hopkins University
733 N BroadwayBaltimoreMD21205520595110501(c)(3)$120,000BASIC RESEARCH
Vaccine & Gene Therapy Institute of Florida
9801 SW Discovery WayPt St LucieFL34987364631835501(c)(3)$120,000BASIC RESEARCH
Northwestern Unversity
303 E Superior StChicagoIL60611362167817501(c)(3)$120,000BASIC RESEARCH
Regents of the University of California
3333 California StSan FranciscoCA94143946036493501(c)(3)$120,000BASIC RESEARCH
John Hopkins University
733 N BroadwayBaltimoreMD21205520595110501(c)(3)$120,000BASIC RESEARCH
Case Western Reserve University
10900 Euclid AveClevelandOH44106341018992501(c)(3)$120,000BASIC RESEARCH
Blood Systems Inc
270 Masonic AveSan FranciscoCA94118860098929501(c)(3)$126,580BASIC RESEARCH
Case Western Reserve University
10900 Euclid AveClevelandOH44106341018992501(c)(3)$140,507BASIC RESEARCH
Vaccine & Gene Therapy Institute of Florida
9801 SW Discovery WayPt St LucieFL34987364631835501(c)(3)$146,029BASIC RESEARCH
University of Pittsburgh
123 University PlacePittsburghPA15213250965591501(c)(3)$167,804MSM INITIATIVES
Case Western Reserve University
10900 Euclid AveClevelandOH44106341018992501(c)(3)$185,130BASIC RESEARCH
The Brigham and Women's Hospital Inc
75 Francis StreetBostonMA02115042312909501(c)(3)$191,039BASIC RESEARCH
University of California Los Angeles
11000 Kinross AveLos AngelesCA90095956006143501(c)(3)$200,000BASIC RESEARCH
Massachusetts General Hospital
55 Fruit StreetBostonMA02114042697983501(c)(3)$212,441BASIC RESEARCH
Case Western Reserve University
10900 Euclid AveClevelandOH44106341018992501(c)(3)$233,309BASIC RESEARCH
Vaccine & Gene Therapy Institute of Florida
9801 SW Discovery WayPt St LucieFL34987364631835501(c)(3)$393,524BASIC RESEARCH
FieldValueIRS element (for citing)
Total501c3 Org63Total501c3OrgCnt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceGrants and AssistanceFormAndLineReferenceDesc
ExplanationPart I, Line 2 amfAR provides grants and fellowships to independent not-for-profit organizations through a peer-review process. Grant applications are first reviewed by the Foundation's volunteer scientific advisory committee, which comprises recognized experts in the medical, scientific, and social sciences disciplines relevant to HIV and AIDS. The scientific advisory committee then sends its evaluations to one of the three committees (research, global initiatives or public policy) of the Foundation's program board, which serves in an advisory capacity to the Board of Trustees. After a program committee has completed its review of the applications, it presents its funding recommendations to amfAR's executive committee and/or the full Board of Trustees for final approval and funding authorization. Grants and fellowships are payable over a one-to-three-year period, and are revocable at amfAR's option if the recipient's performance or use of funds is not consistent with the terms of the grant or fellowships. In certain cases, the actual amounts paid under grants and fellowship awards may be less than the original award if the recipient does not use the full amount awarded. Therefore, a reserve for unexpended grants and fellowships has been recorded. Subawards are grants awarded to not-for-profit organizations to support the costs of collaboration and participation in HIV/AIDS-related research projects for which amfAR has secured restricted funds. Subawards are payable over a one-year period, although advance payments, in full or in part, may be issued following execution of the subaward agreement. Subawards are contingent upon the availability of funds and are revocable if the recipients' performance or use of funds is not consistent with the subaward terms.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Compensation CommitteeYes (X)CompensationCommitteeInd
Independent ConsultantYes (X)IndependentConsultantInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance PaymentfalseSeverancePaymentInd
Supplemental Nonqual Rtr PlanYes (true)SupplementalNonqualRtrPlanInd
Equity Based Comp ArrngmfalseEquityBasedCompArrngmInd
Comp Based On Revenue Of Flng OrgfalseCompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related OrgsfalseCompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng OrgfalseCompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd OrgsfalseCompBsdNetEarnsRltdOrgsInd
Any Non Fixed PaymentsfalseAnyNonFixedPaymentsInd
Initial Contract ExceptionfalseInitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (15 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtBonus Filing OrganizationBonusFilingOrganizationAmount
Kevin Frost
Chief Executive Officer$374,093$37,373$94,850$45,331$551,647$37,373
Bradley Jensen
Assistant Treasurer, Cfo$225,977$16,089$35,062$277,128
John F Logan JD PhD
AssT Sec, Vp, GEN COUNSEL$210,168$14,904$11,419$236,491
Rowena Johnston
AsSt Secretary, Vice PresIDENT$173,783$12,205$11,419$197,407
Edward Donnelly
Asst Treasurer, ControlleR$139,447$10,188$10,476$160,111
Eric Muscatell
Vice President of Development$164,114$0$11,727$11,419$187,260$0
Christopher Collins
Vice President, Public Policy$190,478$13,483$35,062$239,023
Annette Sohn
Vice President, TREAT Asia PGM$200,792$14,505$5,576$220,873
AnnMarie Shannahan
Vice President, Public Info.$200,861$14,150$11,419$226,430
Andrew McInness
Director, Publications$142,695$10,271$35,062$188,028
Anthony Ancona
Vice President, Human Resource$158,957$11,373$11,419$181,749
Susan Doster
Chief Technology Officer$132,756$9,604$15,885$158,245
Bennah Serfaty
Sr Director of CommunicatiON$113,800$8,164$35,062$157,026
Raoul Norman Tenazas
Creative Director$110,187$8,037$35,062$153,286
GREGORY L BOROFF
VP, DEVELOPMENT$155,189$11,017$6,632$172,838

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceCompensationFormAndLineReferenceDesc
ExplanationPart I, Line 4 Chief Executive Officer, Kevin Frost, participated in a supplemental nonqualified retirement plan. Amfar contributed $59,500 into Mr. Frost's non-qualified retirement plan; in additon mr. Frost received $37,373 distribution from the plan that is reported in column (b)(iii).ExplanationTxt

Schedule M IRS990ScheduleM

FieldValueIRS element (for citing)
Works Of ArtWorksOfArtGrp
Art Historical TreasuresArtHistoricalTreasuresGrp
Art Fractional InterestArtFractionalInterestGrp
Books And PublicationsBooksAndPublicationsGrp
Clothing And Household GoodsClothingAndHouseholdGoodsGrp
Cars And Other VehiclesCarsAndOtherVehiclesGrp
Boats And PlanesBoatsAndPlanesGrp
Intellectual PropertyIntellectualPropertyGrp

Securities Publicly Traded SecuritiesPubliclyTradedGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
Contribution18ContributionCnt
Noncash Contributions Rpt F990$199,065NoncashContributionsRptF990Amt
Method Of Determining Revenuessales priceMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Securities Closely Held StockSecuritiesCloselyHeldStockGrp
Secur Prtnrshp Trust IntrstsSecurPrtnrshpTrustIntrstsGrp
Securities MiscellaneousSecuritiesMiscellaneousGrp
Qualified Contrib Hist StructQualifiedContribHistStructGrp
Qualified Contrib OtherQualifiedContribOtherGrp
Real Estate ResidentialRealEstateResidentialGrp
Real Estate CommercialRealEstateCommercialGrp
Real Estate OtherRealEstateOtherGrp
CollectiblesCollectiblesGrp
Food InventoryFoodInventoryGrp
Drugs And Medical SuppliesDrugsAndMedicalSuppliesGrp
TaxidermyTaxidermyGrp
Historical ArtifactsHistoricalArtifactsGrp
Scientific SpecimensScientificSpecimensGrp
Archaeological ArtifactsArchaeologicalArtifactsGrp
Any Property That Must Be HeldfalseAnyPropertyThatMustBeHeldInd
Review Process Unusual NC GiftsYes (true)ReviewProcessUnusualNCGiftsInd
Third Parties UsedfalseThirdPartiesUsedInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceForm 990, Schedule M, line 31FormAndLineReferenceDesc
ExplanationTo the extent that amFAR receives non-standard contributions, the organization's policy is to liquidate those items into cash for eventual use in support of the organization's mission.ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (9 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Program Service Accomplishments(1)Part III, Line 4a-4d(1) Line 4a: Research: amfAR supports research projects that explore novel approaches to scientifically sound but untested hypotheses in all areas of research on HIV/AIDS, funding goal-oriented studies that often lack the preliminary data required for support from traditional grant-makers. The Foundation plays a vital role in HIV/AIDS research, identifying critical gaps in knowledge and providing essential seed money that enables grantees and fellows to test the merits of new concepts or technologies that subsequently can be validated through large-scale studies, such as those funded by the U.S. National Institutes of Health. amfAR fellowships allow talented young investigators to conduct original investigations under the guidance of experienced scientists, helping to ensure the long-term vitality of AIDS research. New Grants and Fellowships Grants and fellowships are awarded through a rigorous process of peer review by a team of independent HIV/AIDS experts drawn largely from the volunteer scientists on amfAR's Scientific Advisory Committee. Guided by its scientific advisors and with the approval of its board of trustees, amfAR pursues a strategic research plan that focuses on the treatment, prevention, and cure of HIV/AIDS. In FY2014, amfAR awarded nearly $7 million in grants and fellowships to support 34 research projects. Six researchers received Mathilde Krim Fellowships in Basic Biomedical Research, an initiative that provides funding for exceptional young researchers who are new to the field of HIV/AIDS research. The initiative has already achieved spectacular results, including numerous published studies in major scientific journals. The 2014 Krim Fellows-each of whom received $150,000-are working on projects focused on HIV/AIDS cure and epidemiological research and vaccine and treatment development. Among the 2014 fellows is Dr. Damien Tully of Massachusetts General Hospital, Cambridge, MA, who is using his amfAR funding to study tissue from mouse models and recently infected people to better understand how the virus spreads once infection occurs. HIV is usually transmitted through mucosal membranes, such as at the vagina or rectum, but eventually the virus wreaks its havoc in the intestines. Under the guidance of mentor Dr. Todd Allen, Dr. Tully aims to understand how the virus spreads and evolves in the body and to generate vital information for the development of a vaccine and possibly a cure. Cure-Focused Studies The search for a cure for HIV/AIDS is at the center of amfAR's research efforts. In FY2014, through the amfAR Research Consortium on HIV Eradication (ARCHE) program and other targeted grants, the Foundation awarded over $6 million toward cure-focused research. Countdown to a Cure for AIDS In February 2014, amfAR launched the Countdown to a Cure for AIDS, a research initiative aimed at developing the scientific basis for a cure for HIV by 2020. In support of the Countdown, amfAR plans to strategically invest $100 million in cure research over the next six years. amfAR Research Consortium on HIV Eradication The Foundation launched ARCHE in 2010 to encourage teams of distinguished scientists from across the globe to work collaboratively on cure-focused research and to provide them with the resources to do so. Since its inception, ARCHE funding has supported the work of 86 research teams pursuing cure-focused studies at 51 institutions on five continents. In July, more than $2.4 million in funding went to seven collaborative teams of researchers working in countries including the United States, the United Kingdom, the Netherlands, Finland, France, Germany, Spain, Sweden, Thailand, and Australia on studies exploring potential strategies for characterizing viral reservoirs-a major obstacle to a cure-and eliminating HIV infection from the body. The largest award in this round of grants is supporting a consortium of European researchers studying the outcomes of HIV patients who undergo different types of stem cell transplants. Timothy Brown, the first and only person known to have been cured of HIV, received a stem cell transplant from a donor with a rare genetic mutation conferring resistance to HIV infection. The research team, led by Dr. Javier Martinez-Picado of Irsi Caixa in Spain and Dr. Annemarie Wensing of University Medical Center Utrecht in the Netherlands, anticipate having several HIV patients in need of stem cell transplants and hope to generate new knowledge that can inform more widely applicable interventions. A team of researchers in the U.S. will receive funding to address one of the most pressing challenges in HIV research: determining whether people whose HIV has dropped to an undetectable level have been cured, or whether current tests are simply not sensitive enough to detect every last remnant of virus. In a recent amfAR-funded study, Dr. Timothy Henrich of Brigham and Women's Hospital in Boston described two patients who had received stem cell transplants to treat their cancer and in whom HIV could no longer be detected using the most sophisticated tests currently available. When the patients stopped taking antiretroviral therapy, their virus eventually returned, indicating that they had not been cured. Dr. Henrich is collaborating with Dr. Ramesh Akkina of Colorado State University in an effort to infuse cells taken from the Boston patients prior to viral rebound into mice engineered to contain human immune systems. If the mice become infected, this would represent a more sensitive test of HIV persistence than any other test currently available. Targeted Grants for HIV Cure Research In February 2014, amfAR awarded 12 targeted grants totaling more than $2.15 million to leading researchers from around the world who are working on a variety of cutting-edge, cure-focused studies. These projects include research aimed at therapeutic vaccine development, expanding our understanding of latent viral reservoirs, and examining pharmacological and gene therapy approaches to curing HIV. Dr. Nancy Haigwood and her colleagues at Oregon Health and Science University in Portland are testing the ability of antibodies to limit the establishment of the viral reservoir in newborns infected with HIV. In a study that could inform our understanding of how and when the reservoir is established, Dr. Haigwood's team is testing in infant macaques the effects of antibodies found to be effective in controlling HIV in humans. At the University of California, San Francisco, Dr. Hiroyu Hatano and colleagues are recruiting subjects from ongoing studies of PrEP (pre-exposure prophylaxis). Because these study participants are frequently tested for HIV, Dr. Hatano believes her team will be able to identify subjects in the first couple of weeks of infection, when the viral reservoirs are established. This will allow the researchers to discover which cells HIV infects at various stages during acute infection and how very early treatment might affect the size or distribution of the reservoir. A team of researchers at the University of Toronto led by Dr. Mario Ostrowski is pursuing an entirely different strategy: therapeutic vaccination. Dr. Ostrowski and colleagues are conducting a small pilot clinical trial of a therapeutic vaccine to determine whether it can reduce the size of the reservoir. The vaccine will be tested in subjects who started antiretroviral therapy within six months of acquiring HIV and is intended to induce cellular immunity, one arm of the immune system responsible for killing cells that are infected with the virus. Published Research Research studies make the greatest impact on the AIDS field and on the broader scientific community when they are published in scientific journals. In the past year, at least 49 scientific publications resulted from amfAR-funded research. Killer Immunity and HIV Reservoirs In the January issue of the Journal of Acquired Immune Deficiency Syndromes, amfAR grantee Dr. Mathias Lichterfeld reported on the immune responses of "elite controllers," people infected with HIV but capable of maintaining low viral loads and high T cell counts without the aid of antiretroviral therapy. Dr. Lichterfeld, working at Harvard University and Massachusetts General Hospital, along with colleagues there and at China Medical University in Shenyang, focused on a major player in the T cell immune system: the CD8+ cytotoxic cell. These "killer T cells" are capable of destroying cells infected with viruses. The research team found that the CD8+ T cells' ability to kill HIV-infected cells was significantly greater in elite controllers than in patients requiring antiretroviral therapy to suppress virus. Of even greater interest, further studies showed a consistent relationship among a genetic marker called MHC-1 B57, high killer T cell activity, and low virus reservoir. In addition, the effect was most pronounced in nave T cells-a type of immune cell that constitutes the reservoir but has
Program Service Accomplishments (2)Part III, Line 4a-4d (2) Line 4b: TREAT ASIA: amfAR's TREAT Asia program (Therapeutics Research, Education, and AIDS Training in Asia) is a network of hospitals, clinics, and research institutions working with civil society to ensure the safe and effective delivery of HIV/AIDS treatments across Asia and the Pacific. The TREAT Asia Network encompasses 21 adult and 18 pediatric sites throughout the region, which collaborate on a variety of projects. TREAT Asia HIV Observational Database (TAHOD) TREAT Asia pioneered the region's first adult observational database for HIV/AIDS, which now includes anonymous data collected from approximately 9,000 patients at 21 clinical sites in 12 countries. The information gathered and analysed through the database informs the development of more effective research and treatment programs, and helps define treatment standards specific to HIV/AIDS in Asia. In FY2014, the TAHOD network launched a multi-site clinical study in Asia that addresses obstacles to treating hepatitis C among those co-infected with HIV in four countries: Indonesia, Malaysia, Thailand, and Vietnam. The study began with a screening to assess how many HIV-positive patients in TREAT Asia participating clinics in these countries needed to start treatment for hepatitis C. At the end of September, the study had enrolled approximately 135 patients in treatment, and will continue to enroll up to 200 patients. The study aims to develop a pilot model of care for treating hepatitis C in resource-limited settings that can be replicated throughout the region, where treatment for the disease is costly and often inaccessible. International AIDS Database TREAT Asia manages the Asia-Pacific section of the International Epidemiologic Databases to Evaluate AIDS (IeDEA), a global collaboration established by the U.S. National Institute of Allergy and Infectious Diseases. TREAT Asia Pediatric Network TREAT Asia's Pediatric Network includes 18 sites in six countries; these sites share information and best practices in an effort to improve the quality of pediatric care in the region. The TREAT Asia Pediatric HIV Observational Database (TApHOD) was modeled on the adult database and includes data from approximately 5,500 pediatric patients at 18 clinical sites in Cambodia, India, Indonesia, Malaysia, Thailand, and Vietnam. In FY2014, the TREAT Asia Studies to Evaluate Resistance, Pediatrics (TASER-P) completed core activities of a three-year study on how children and adolescents who had developed resistance to first-line antiretrovirals (ARV) responded and adhered to second-line treatment. Ongoing analysis has provided insights into how to improve long-term ARV management in children and adolescents. TREAT Asia will continue to follow approximately 60 children who have developed resistance to second-line treatment for another two years in order to better understand which third-line ARVs will be most needed in the region. Adolescent Research In FY2014, TREAT Asia conducted several studies on how HIV affects adolescents physically, socially, and emotionally. TREAT Asia's pediatric sites conducted local studies among their adolescent HIV patients to investigate HIV's impact on their health and developmental needs. Among other issues, they investigated adolescents' reproductive and sexual health needs, liver function, treatment failure, treatment adherence, and the impact of orphanhood, disclosure, and school attendance on antiretroviral outcomes. In addition, TREAT Asia is conducting an ongoing study using an audio-computer-assisted survey instrument (ACASI) to better understand how adolescents experience living with HIV by allowing them to anonymously respond to questions using a computer interface about whether they are taking their medicines; if they have tried alcohol, tobacco, or other drugs; their sexual behavior; and stigma they may have experienced at school or at home. Exploring Links Between HIV and Cancer Among HIV-positive men who have sex with men (MSM), the risk of anal cancer is twice the level of those who are HIV-negative, but little research has been done on this issue in Asia. In 2009, using funding from IeDEA, TREAT Asia began supporting an innovative research study exploring the links between HIV and anal cancer and looking at cancer biomarkers in an attempt to better identify MSM with pre-cancerous anal lesions. Research on human papillomavirus (HPV) and anal cancer risk among MSM is ongoing at sites in Bangkok, Bali, and Jakarta. Building Research and Treatment Capacity TREAT Asia has implemented a research education program to help network members strengthen their skills in conducting clinical research and to boost the overall quality of care in the region. TREAT Asia organized 10 workshops and training sessions in FY2014, including sessions for health providers on managing HIV and hepatitis C co-infection, treating men who have sex with men, clinical management of pediatric HIV, rights and legal protections for women living with HIV, and communication skills to promote early HIV testing and treatment. Building Community Treatment Literacy and Promoting Advocacy for Treatment Access Communicating treatment information about a disease as complex as HIV/AIDS can be daunting, but patients' lives depend on it. TREAT Asia works closely with regional organizations to support treatment literacy activities, including the production of "community-friendly" educational brochures on HIV treatment standards in local languages. In FY2014, TREAT Asia developed three fictional videos on the sexual and reproductive health and rights of women living with HIV that provide examples of both positive and negative advice that HIV-positive pregnant women might receive from healthcare professionals. The videos are in Thai and have English subtitles. They are available on TREAT Asia's webpage and its public YouTube channel. In addition, TREAT Asia released a policy brief titled Hepatitis C and HIV: Addressing the Dual Epidemic, which summarizes hepatitis C disease progression, treatment, and advocacy priorities. It also produced a fact sheet providing a summary of the key recommendations in the first World Health Organization guidelines on the screening, care, and treatment of persons with hepatitis C infection. TREAT Asia also held a regional meeting on improving access to hepatitis C treatment, which was attended by 20 advocates from six South and Southeast Asian countries. TREAT Asia also continued to publish lay-language articles on AIDS research, policy, and community issues facing the TREAT Asia network and the Asia-Pacific as a whole. The articles appear in the TREAT Asia Report, a bimonthly e-newsletter, and on TREAT Asia's website, www.treatasia.org. 20th International AIDS Conference TREAT Asia was well represented at the main and pre-conference events in July 2014 in Melbourne, Australia. TREAT Asia staff and network investigators participated in pre-conference workshops on HIV pediatric and HIV cure research. At the pediatric workshop, presentations were made on two TREAT Asia studies and one IeDEA multi-regional analysis (duration of initial antiretroviral therapy). At the main conference, additional TREAT Asia studies were presented on adherence to treatment and experiences of stigma among adolescents, hepatitis C co-infection and liver disease, and 10-year treatment outcomes in TREAT Asia's regional adult HIV cohort. Dr. Annette Sohn, amfAR vice president and director of the TREAT Asia program, was invited to give oral presentations on key at-risk populations in Asia, non-communicable diseases in resource-limited settings, and pediatric and adolescent HIV.
Program Service Accomplishments (3)Part III, Line 4a-4d (3) Line 4c: EDUCATION AND INFORMATION: amfAR seeks to translate and disseminate information on important AIDS-related research, treatment, prevention, and policy issues for diverse audiences and to increase broad awareness and knowledge of the pandemic. amfAR also publishes a wide range of educational materials, maintains an informative website, and engages respected public figures, HIV/AIDS scientists, and policymakers in communicating the need for continued research to develop new methods of prevention, treatment, and, ultimately, a cure for AIDS. Educational Materials amfAR produces a range of periodicals in both print and electronic formats, including its newsletter Innovations, published twice a year and distributed to more than 45,000 people; the TREAT Asia Report, an e-mail newsletter distributed six times a year to more than 4,000 readers in the international health community; and a monthly e-mail newsletter distributed to nearly 100,000 people. The Foundation's website features news, interviews, blog posts, and other original articles covering science, policy, the global epidemic, and amfAR programs and activities. amfAR also creates and distributes program reports, press releases, and updates on major HIV/AIDS issues, and conducts public service advertising campaigns that have been instrumental in educating policymakers, healthcare professionals, people living with HIV/AIDS, and the general public. Social Media amfAR vigorously expanded its presence in the social media arena, reaching large numbers of people, including a younger demographic that is often less educated about HIV and the AIDS epidemic. The Foundation regularly added content to its Facebook page and live tweeted and posted images on Instagram from fundraising and program events. amfAR has 57,000 likes on Facebook, 29,000 Twitter followers, and nearly 33,000 Instagram followers. Media Outreach amfAR continued to work closely with the media to raise the profile of HIV/AIDS, both domestically and internationally, and to help ensure the accuracy of AIDS-related press coverage. Articles and reports involving amfAR-many of which included interviews with amfAR spokespeople-were carried in numerous media outlets, including the New York Times, The Wall Street Journal, The Washington Post, and The Huffington Post, and news agencies such as the Associated Press, CNN, Bloomberg News, and Reuters. amfAR's public awareness efforts are greatly enhanced by the committed support of public figures who lend their voices and donate their time, talents, and resources to help sustain the Foundation's mission. Support of amfAR by prominent public figures began with the late Dame Elizabeth Taylor, and others have followed in her footsteps. amfAR is profoundly grateful for the continuing steadfast support of Global Fundraising Chairman Sharon Stone. In FY2014, celebrity supporters included amfAR Ambassadors Cheyenne Jackson, Janet Jackson, Milla Jovovich, Liza Minnelli, and Michelle Yeoh, as well as Dame Shirley Bassey, Justin Bieber, Mary J. Blige, Jessica Chastain, Sofia Coppola, Alan Cumming, Willem Dafoe, Leonardo DiCaprio, Jane Fonda, Grace Jones, Heidi Klum, Julianna Margulies, Kylie Minogue, Aishwarya Rai and Abhishek Bachchan, Lana Del Rey, Michelle Rodriguez, Diana Ross, and Dita Von Teese, among many others.
Program Service Accomplishments (4)Part III, Line 4a-4d (4) THE GMT INITIATIVE: Since 2007, amfAR has been serving the HIV-related needs of gay men, other men who have sex with men (MSM), and transgender individuals (collectively, GMT) throughout the developing world through its GMT Initiative. Through small, targeted grants to grassroots groups, amfAR helps expand access to HIV education and prevention services; supports advocacy aimed at increasing funding for prevention and treatment services; and works to end the stigma, discrimination, and violence that threaten the lives of GMT and fuel the spread of HIV/AIDS. Community Awards In FY2014, amfAR awarded approximately $300,000 to 15 groups in Africa and Latin America for a wide range of projects addressing HIV prevention, outreach, education, advocacy, testing, research, and capacity building. Sample funded projects include: Africa Alternatives-Cameroun (Douala, Cameroon) Alternatives used its fifth year of GMT Initiative support to integrate peer-led strategies with clinical services to increase LGBT individuals' access to HIV prevention, care, and treatment in Douala. Alternatives mobilized their peer educators across the city to hold discussions on HIV/AIDS and STI prevention and treatment, while also promoting the services at its Access Center to increase the patient roster. In addition to the comprehensive medical services offered at the Access Center, Alternatives offered mobile testing and organized testing awareness days to reach a broader number of LGBT through HIV testing. Action Humanitaire Pour la Sant et le Dveloppement Communautaire (AHUSADEC) (Bukavu, Democratic Republic of the Congo) In its second year of amfAR support, AHUSADEC improved its referral system for GMT-friendly public healthcare centers in Bukavu to improve the ability of GMT to access health services and HIV testing and treatment. It also empowered GMT sex workers by providing HIV prevention information. In addition, AHUSADEC hosted training workshops for healthcare workers at the GMT-friendly testing centers to ensure a stigma-free environment and launched a media campaign addressing HIV-related issues. Latin America Asociacin de Travestis, Transexuales, y Transgeneros de Argentina Asociacin Civil (ATTTA) (Buenos Aires, Argentina) ATTTA conducted a survey on attitudes, behaviors, and practices regarding sexual health and HIV prevention and risks for 180 transgender women and 40 of their stable partners in Buenos Aires, Argentina. The survey results were used to establish baseline behavioral data to inform policies and programs for transgender women. In addition, ATTTA established baseline HIV prevalence data by offering rapid HIV testing and counseling to all clients seeking services at their mobile health unit. The group also evaluated the acceptability of these services and referred all those with positive results directly to partner clinics. Red Nacional de Mujeres Travestis, Transexuales y Transgeneros de Bolivia (RED TREBOL) (Cochabamba, Bolivia) RED TREBOL used its third consecutive grant from amfAR to create the first trans-specific health center in Cochabamba. RED TREBOL established a physical space for the clinic and began to train peer educators to promote the clinic and its services and distribute referrals for the clinic to create demand. A medical team that provides services for RED TREBOL at their mobile unit program began offering HIV testing and counseling, hormones and hormonal guidance, STI prevention and treatment services, and mental health services at the clinic. "In Action" Awards Using two-year funding from the Arcus Foundation, the GMT Initiative supported four organizations as part of its Advocacy in Action program, which engages GMT-led community-based organizations that wish to influence the policies of governments and external donors. Ten organizations were supported through its Evidence in Action program, which documents and evaluates the impact of community-based programs with the ultimate goal of implementing the most workable strategies for stopping the spread of HIV/AIDS. Evidence in Action was developed with support from ViiV Healthcare's Positive Action Program and the Elton John AIDS Foundation. Publications As part of its efforts to raise awareness among governments, donors, and international nongovernmental organizations about the spread of HIV among GMT individuals and to advocate for effective strategies to address it, amfAR publishes reports on HIV and GMT. In FY2014, the GMT Initiative published two reports in its "Lessons from the Front Lines" series. The first, Lessons From the Front Lines: Research Impact Analysis, outlined some of the most successful community-led research studies GMT grantee partners have implemented to improve HIV testing, treatment, and awareness in five regions-Africa, Asia-Pacific, the Caribbean, Eastern Europe and Central Asia, and Latin America. The second, Lessons From the Front Lines: Trans Health and Rights, produced in collaboration with Global Action for Trans Equality (GATE), examined the challenges faced by 10 grantee partners-many of which were led by transgender individuals-and assessed their progress. The GMT Initiative also created a series of fact sheets in English, French, and Spanish on emerging HIV prevention technologies that explain each technology and serve as a tool to help GMT advocates advocate for the interventions' increased availability worldwide. Symposia and Conferences In January 2014, the GMT Initiative supported and attended a meeting hosted by the University of West Indies (UWI) and Columbia University engaging GMT community organization grantee partners, researchers, government officials, and other key stakeholders to develop a formalized GMT-related research agenda for Jamaica. Based on a similar program amfAR funded in South Africa, UWI and Columbia University used the meeting to formulate a research plan for submission to the U.S. National Institutes of Health for funding. In May, amfAR partnered with the Gay and Lesbian Coalition of Kenya (GALCK) and the International AIDS Vaccine Initiative (IAVI) to sponsor a meeting between LGBT community members and social/behavioral researchers in Kenya to formulate a community-led research agenda on LGBT health. The GMT Initiative played an active role at the 2014 International AIDS Conference and the MSM pre-conference in Melbourne, Australia. Eighteen GMT activists and grantee partners received support from amfAR to attend the conference. All had at least one presentation during the conference, with many speaking on multiple panels and poster sessions. GMT Initiative staff convened nine sessions on topics including the results and lessons learned from its Evidence in Action program, transgender health and rights, information and communication technology use in HIV efforts targeting GMT individuals, lubricant access, and safety and security in conducting HIV research with GMT in rights-constrained settings. In addition, the GMT Initiative hosted a donor meeting on transgender issues and a grantee exchange meeting (in conjunction with the Public Policy office) for 24 representatives from current grantee partners.
Program Service Accomplishments (5)Part III, Line 4a-4d (5) public policy: Informed by thorough research and analysis, amfAR is a highly respected advocate of rational and compassionate AIDS-related public policy. The Foundation is engaged in efforts to secure necessary increases in funding for HIV/AIDS research; implement the U.S. National HIV/AIDS Strategy; expand access to care and treatment; and protect the civil rights of all people affected by HIV/AIDS. Capitol Hill Briefings The Role of HIV Research in Ending AIDS: New Developments in HIV Vaccine and Prevention Science, November 18, 2013 amfAR co-sponsored this briefing with AVAC: Global Advocacy for HIV Prevention, the Center for Global Health Policy, and the International AIDS Vaccine Initiative, in cooperation with Congresswoman Barbara Lee. Speakers included Carl Dieffenbach, director of NIAID's Division of AIDS; Fred Sawe, deputy director of Kenya Medical Research Institute/Walter Reed Project; Christina Polyak, research physician at the Military HIV Research Program, Walter Reed Army Institute of Research; and Margaret McGlynn, president and chief executive officer of the International AIDS Vaccine Initiative. Christine Lubinski, executive director of the Center for Global Health Policy, and Kevin Fisher, policy director of AVAC: Global Advocacy for HIV Prevention, acted as moderators. Making AIDS History: From Science to Solutions, April 30, 2014 amfAR convened a panel of leading government, research, policy, and advocacy experts in Washington, D.C., to discuss recent progress in the fight against HIV/AIDS, both domestically and globally. Participants included Dr. Jim Yong Kim, president of the World Bank Group; Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health; Dr. Deborah Birx, Ambassador-at-Large and U.S. Global AIDS Coordinator; Michel Sidib, executive director of UNAIDS; Judy Woodruff, co-anchor of PBS NewsHour; Dr. Paul Farmer, co-founder of Partners in Health and chair of Harvard Medical School's Department of Global Health and Social Medicine; and Douglas Brooks, director of the White House Office of National AIDS Policy; among others. Members of Congress, including House Democratic Leader Nancy Pelosi, Senator Tom Harkin, and Congressman Jim Himes, also spoke at the briefing organized by Dr. Susan Blumenthal, amfAR's senior policy and medical advisor and former U.S. Assistant Surgeon General. Shaping the Domestic Response to HIV/AIDS amfAR has long advocated the implementation of a comprehensive national HIV/AIDS strategy to address the epidemic in the U.S., where more than 1 million people are living with the virus. In FY2014, amfAR produced a number of opinion pieces, issue briefs, special reports, and infographics addressing important domestic topics, such as funding for AIDS research and U.S. HIV/AIDS programs, Medicaid expansion's effect on HIV health services in the U.S., and HIV prevention among key populations, specifically transgender individuals and black MSM. In December 2013, amfAR partnered with the Treatment Action Group (TAG) to issue a report titled Filling the Gaps in the U.S. HIV Treatment Cascade: Developing a Community Driven Research Agenda that outlined research needed to improve outcomes on the domestic HIV treatment cascade and ensure more people are engaged and retained in HIV care. The two groups then jointly held a series of meetings with government officials on next steps to enact the agenda. As one of the earliest supporters of comprehensive harm reduction programs for people who inject drugs (PWID), including syringe exchange, amfAR has played a leading role in advocating the implementation of these lifesaving HIV prevention programs. In FY2014, amfAR continued to advocate overturning the ban on federal funding of syringe services programs. Global Health amfAR produced a special report with AVAC: Global Advocacy for HIV Prevention outlining the need for a new approach to tracking data to guide the key decisions that shape the global response to the HIV/AIDS epidemic. The report, titled Data Watch: Closing a Persistent Gap in the AIDS Response, updates amfAR's and AVAC's 2012 Action Agenda to End AIDS, which made the case for a more businesslike approach to ending the epidemic and proposed a multi-year plan with concrete strategies, targets, and timelines. amfAR also partnered with AVAC to place an opinion piece written by Chris Collins, former amfAR vice president and director of Public Policy, and Mitchell Warren, executive director of AVAC, titled "Time to Tip the Scales in Favor of Ending AIDS" in the Huffington Post to accompany the report. The editorial was also posted on POZ.com and the Kaiser Daily Summary. Additionally, in FY2014, amfAR reported on the need for funding for the global AIDS response through opinion pieces, issue briefs, and infographics, with specific attention to how funding cuts to the President's Emergency Plan for AIDS Relief (PEPFAR) and the Global Fund to Fight AIDS, Tuberculosis and Malaria would undermine a decade's worth of progress in scaling up treatment and care. In January 2014, Dr. Susan Blumenthal, amfAR senior policy and medical advisor, placed an opinion piece in the Huffington Post titled "Our Shared Responsibility: Ending AIDS, Tuberculosis, and Malaria." Public Policy also continued to advocate for sound, evidence-based policies to address HIV among key populations globally. In FY2014, Kali Lindsey, deputy director of the Public Policy Office, traveled to Kenya and Vietnam to discuss efforts to scale up access to syringe exchange, methadone, and ARV for PWID. Gay men, other men who have sex with men, and transgender individuals-collectively referred to as GMT-remain one of the hardest hit and most underserved populations in the global HIV/AIDS epidemic. amfAR's policy office works closely with the Foundation's GMT Initiative to advocate for expanded access to HIV prevention and treatment services for GMT worldwide, and to fight the stigma and discrimination that make GMT more vulnerable to HIV infection and inhibit equal access to care. In March, amfAR Founding Chairman Dr. Mathilde Krim and amfAR Trustee Harry Belafonte expressed their grave concern over new anti-LGBT laws in Uganda and Nigeria in an opinion piece for CNN.com.
Policiesform 990, part vi, section b Line 11 - The Form 990 was prepared by a nationally renowned accounting firm in conjunction with the organization's financial department. A copy of the draft Form 990 was circulated to the full Board of Trustees for discussion and comment. Each Board Member was provided ample opportunity to comment on the information contained in the 990 prior to its filing with the Internal Revenue Service. Line 12 - Each officer, director, trustee and key employee of amFar ("foundation") is required to annually disclose any conflicts of interest that arise by virtue of employment, board service, or position with the foundation. The foundation monitors compliance with its conflict of interest policy through an annual questionnaire/disclosure statement that is distributed to these individuals. Potential conflicts are investigated immediately. LINE 15 -AMFAR ("FOUNDATION FOR AIDS RESEARCH") UNDERTAKES A THOROUGH PROCESS TO ENSURE THAT THE COMPENSATION IT PAYS TO ITS TOP MANAGEMENT OFFICIAL AND ALL OF ITS OFFICERS AND KEY EMPLOYEES IS REASONABLE GIVEN THE MARKET IN WHICH THE FOUNDATION OPERATES. AN INDEPENDENT CONSULTING FIRM QUALIFIED IN THE AREA OF NONPROFIT COMPENSATION PREPARES AN ANALYSIS OF MARKET COMPENSATION RANGES BY JOB FUNCTION AND PRESENTS IT TO THE COMPENSATION COMMITTEE OF THE BOARD. ON THE BASIS OF THIS INFORMATION, STAFF COMPENSATION IS DETERMINED ACCORDING TO SALARY RANGES APPROVED BY THE COMPENSATION COMMITTEE OF THE BOARD, IN CONSULTATION WITH THE CEO AND CFO. CEO COMPENSATION IS REVIEWED AND DETERMINED BY THE COMPENSATION COMMITTEE OF THE BOARD UTILIZING THE INDEPENDENT CONSULTANT ANALYSIS.
DisclosureForm 990, Part VI, Section C LIne 19 - amfar makes its Form 990 available to the public by retaining a copy at its place of business and on its website, www.amfar.org. The Form 990 is likewise published on the internet at www.guidestar.org. The Foundation's financial statements are made available in its annual report and on its website. The Foundation's governing documents and conflict of interest policy are not ordinarily made available to the public, but, if requested, will be provided at management's discretion.
Functional ExpensesPart IX, Lines 1 & 3 The Foundation for AIDS Research reports its grants net of grant returns or recoveries. Periodically, grants remitted to charitable organizations are returned to AMFAR for a variety of reason. On Schedules F & I, grants are reported irrespective of whether they were ultimately returned to AMFAR since categorizing the "returned" amounts would be time consuming. Therefore, amounts reported on Part IX, Line 1 will not tie to total grants on Schedule I; amounts reported on Part IX, Line 3 will not tie to total grants on Schedule F.
Other Changes in Net AssetsFORM 990, SECTION XI, LINE 5 CHANGE IN VALUE OF THIRD PARTY TRUST............($33,603) --------- TOTAL LINE 9 ($33,603)

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.